SGK1 and prostate carcinoma: SGK1 also regulates cell growth and survival as a downstream effector of PI3K pathway, and it is overexpressed in some types of tumors including colon cancer, medulloblastoma, prostate cancer, ovarian tumors, and non-small cell lung cancer, but not in all tumors [51, 52].